CJC-1295 is a synthetic peptide that stimulates growth hormone (GH) release in research settings. It belongs to the class of growth hormone-releasing hormone (GHRH) analogs and is intended strictly for laboratory research purposes. Unlike CJC-1295 with DAC, this version has a shorter half-life.
Product Details:
- Product Name: CJC-1295
- CAS Number: 863288-34-0 (same as DAC form)
- Chemical Formula: C165H269N47O44
- IUPAC Name: [D-Ala2, Gln8, Ala15, Leu27]-Sermorelin
- Molecular Mass: 3647.250 g/mol
- Synonyms: CJC-1295; GRF 1-29; Sermorelin analog
Mechanism of Action
CJC-1295 stimulates the pituitary gland to release growth hormone by mimicking natural GHRH. Without the DAC component, its half-life is shorter, leading to more frequent GH pulses rather than prolonged release.
Potential Research Applications
In research contexts, CJC-1295 may:
- Increase growth hormone secretion
- Support studies on muscle growth and recovery
- Aid in fat metabolism research
- Contribute to anti-aging research
- Support sleep studies
- Investigate bone density regulation
- Explore immune system interactions
Clinical Research
Research on CJC-1295 focuses on understanding GH-related pathways, including GH secretion patterns and effects on musculoskeletal and metabolic processes. Studies remain preliminary, and further research is needed to fully assess safety and efficacy.
FAQs
What is the purpose of CJC-1295?
It is used in research to study growth hormone regulation and its effects on the body.
Can this product be used on humans?
No. CJC-1295 is strictly for research purposes and not intended for human or veterinary use.
How should it be stored?
Store in a cool, dry place away from direct sunlight. Follow laboratory handling guidelines.
Are there any known side effects?
Side effects are not fully understood, as studies have been limited to research settings.
Is CJC-1295 legal?
Legality varies by country or region. Always comply with local laws and regulations.
Reviews
There are no reviews yet.